Cargando…

Peroxisome Proliferator-Activated Receptors Family Is Involved in the Response to Treatment and Mild Clinical Course in Patients with Ulcerative Colitis

Background. PPARs play an important role in the regulation of intestinal inflammation. Methods. We included a total of 46 UC patients and 31 controls. The gene expression of PPARs was measured by RT-PCR and protein expression by immunohistochemistry. Results. PPARα gene expression was significantly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto-Furusho, J. K., Jacintez-Cazares, M., Furuzawa-Carballeda, J., Fonseca-Camarillo, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274912/ https://www.ncbi.nlm.nih.gov/pubmed/25548431 http://dx.doi.org/10.1155/2014/932530

Ejemplares similares

Synthesis of Interleukin-10 in Patients with Ulcerative Colitis and Helicobacter pylori Infection
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2020)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis
por: Toledo-Mauriño, Joel Jesús, et al.
Publicado: (2018)

TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis
por: Toledo Mauriño, Joel J., et al.
Publicado: (2020)

Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease
por: Fonseca-Camarillo, Gabriela, et al.
Publicado: (2018)

Indoleamine 2,3-Dioxygenase: Expressing Cells in Inflammatory Bowel Disease—A Cross-Sectional Study
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2013)

Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2018)

Histopathologic Parameters at Diagnosis as Early Predictors of Histologic Remission along the Course of Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2020)

ABCC7/CFTR Expression Is Associated with the Clinical Course of Ulcerative Colitis Patients
por: Villeda-Ramírez, Marco A., et al.
Publicado: (2021)

Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis
por: Camarillo, Gabriela Fonseca, et al.
Publicado: (2020)

Transcript levels of Toll-Like receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis
por: Sánchez-Muñoz, Fausto, et al.
Publicado: (2011)

Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2020)

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire
por: Bueno-Hernández, Nallely, et al.
Publicado: (2015)

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
por: Danese, Silvio, et al.
Publicado: (2018)

The dual role of Escherichia coli in the course of ulcerative colitis
por: Pilarczyk-Zurek, Magdalena, et al.
Publicado: (2016)

Hypereosinophilic Syndrome with Pulmonary Involvement in Ulcerative Colitis
por: Bashir, Anam, et al.
Publicado: (2023)

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
por: Solitano, Virginia, et al.
Publicado: (2020)

Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Severe Ulcerative Colitis as a Complication of Mild COVID-19 Infection in a Vaccinated Patient
por: Fonseca Mora, Maria Camila, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
por: Basso, Paulo José, et al.
Publicado: (2021)

Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
por: Lee, Jin Wook, et al.
Publicado: (2021)

The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis
por: Martin Mena, Anthony, et al.
Publicado: (2017)

Effects of Appendectomy on the Onset and Course of Ulcerative Colitis in Chinese Patients
por: Chen, Dafan, et al.
Publicado: (2018)

Advances of Heat Shock Family in Ulcerative Colitis
por: Gong, Min, et al.
Publicado: (2022)

Peroxisome Proliferators: Response
por: Melnick, R
Publicado: (2001)

Perplexing peroxisome proliferators.
por: Citron, M
Publicado: (1995)

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
por: Kedia, Prashant, et al.
Publicado: (2007)

Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study
por: Häuser, Winfried, et al.
Publicado: (2005)

Surgical Procedure for Sporadic Colorectal Cancer in Patients with Mild Ulcerative Colitis
por: Uchino, Motoi, et al.
Publicado: (2012)

Discrete terminal ileal ulcers in patients diagnosed with ulcerative colitis: clinical significance and natural course
por: Lim, Hyo-Jin, et al.
Publicado: (2021)

Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
por: Narang, Vikram, et al.
Publicado: (2018)

Clinical course of ulcerative colitis patients who develop acute pancreatitis
por: Kim, Jong Wook, et al.
Publicado: (2017)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido, Angelo, et al.
Publicado: (2019)

Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis
por: Nishihara, Yuichiro, et al.
Publicado: (2021)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
por: Adibi, Peyman, et al.
Publicado: (2011)

Peritonsillar Involvement in Pyoderma Gangrenosum associated with Ulcerative Colitis
por: Byeon, Yu Mi, et al.
Publicado: (2014)

Mechanisms Involved in the Enhanced Susceptibility of Senescent Rats to the Hepatocarcinogenic Effect of Peroxisome Proliferators: Role of Peroxisome Proliferator-Activated Receptor alpha (PPAR), Cell Proliferation and Oxidative Stress
por: Youssef, Jihan A., et al.
Publicado: (2001)

Phthalate esters as peroxisome proliferator carcinogens.
por: Warren, J R, et al.
Publicado: (1982)

Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis
por: Miyahara, Koji, et al.
Publicado: (2013)

Arginine improves peroxisome functioning in cells from patients with a mild peroxisome biogenesis disorder
por: Berendse, Kevin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cet903i7vlhsiub4av3qga5dcu